FeesSafety
Pluang+

NCH performs US first tricuspid valve repair with PASCAL Precision system after FDA approval

Market News
29 Oct 2026, 20:00 WIB
Naples Comprehensive Health
View Source
Bullish
NCH performs US first tricuspid valve repair with PASCAL Precision system after FDA approval

Naples Comprehensive Health (NCH) has completed the first tricuspid valve repair in the US using the PASCAL Precision system following FDA approval. This minimally invasive catheter-based procedure offers a new treatment option for patients with severe tricuspid regurgitation, a condition causing heart valve leakage and symptoms like fatigue and shortness of breath. Led by Dr. Robert Cubeddu, the procedure expands care options at NCH Rooney Heart Institute, which has been a key clinical trial site for this therapy. The system is designed for patients at intermediate or higher surgical risk and aims to improve quality of life without open-heart surgery.

The NCH Rooney Heart Institute's milestone in tricuspid valve repair with the PASCAL Precision system provides context for health sector activity. For readers following health stocks, here is Pluang's market snapshot as of Oct 29, 2026 19:12 WIB: out of 150 priced health-sector US stocks, 91 rose and 53 fell. Among notable movers, Amgen (AMGN) rose 3.73% to USD 468.69 with a typical hold time of 73 days and 82% buy orders, Baxter International (BAX) increased 3.69% to USD 26.40 with a 72-day hold, while Vertex Pharmaceuticals (VRTX) gained 3.55% to USD 548.49 but saw a majority of 56% sell orders and a longer hold time of 122 days.

More News

Immunocore to present Phase 1 data on brenetafusp and KIMMTRAK combo for metastatic uveal melanoma at SITC 2026

Immunocore to present Phase 1 data on brenetafusp and KIMMTRAK combo for metastatic uveal melanoma at SITC 2026

Immunocore Holdings will present Phase 1/2 clinical trial data for brenetafusp alone and combined with KIMMTRAK in treating metastatic uveal melanoma at the 2026 Society for Immunotherapy of Cancer meeting. This trial evaluates safety and efficacy in...

Company Fundamentals
Bullish
16 minutes ago
Collegium Pharmaceutical and Boston Legacy FC expand partnership to support neurodivergent youth in Massachusetts sports.

Collegium Pharmaceutical and Boston Legacy FC expand partnership to support neurodivergent youth in Massachusetts sports.

Collegium Pharmaceutical and Boston Legacy FC have extended their partnership to include youth coach training, an annual Sports for All Summit, and sensory inclusion programs aimed at supporting neurodivergent children, especially those with ADHD, in...

Others
Bullish
1 hour ago
Gilat Satellite Networks to attend Deutsche Bank Global Space and Defense Tech Summit in NYC

Gilat Satellite Networks to attend Deutsche Bank Global Space and Defense Tech Summit in NYC

Gilat Satellite Networks announced that its CEO Adi Sfadia and CFO Gil Benyamini will attend the Deutsche Bank Global Space and Defense Tech Summit on November 18, 2026, in New York City. The event will feature one-on-one and group meetings, providin...

Market News
Neutral
1 hour ago
Boralex buys Wind2 to boost UK wind energy projects by 350 MW, expanding its renewable footprint.

Boralex buys Wind2 to boost UK wind energy projects by 350 MW, expanding its renewable footprint.

Boralex Inc. has acquired Wind2, a UK-based renewable energy developer with about 350 MW of advanced wind projects across Scotland, England, and Wales. This acquisition strengthens Boralex's presence and capabilities in the UK, aligning with its stra...

Company Fundamentals
Bullish
2 hours ago
Dimensional Fund Advisors discloses 5.07% stake in Vesuvius PLC shares as of October 28, 2026.

Dimensional Fund Advisors discloses 5.07% stake in Vesuvius PLC shares as of October 28, 2026.

Dimensional Fund Advisors Ltd. disclosed holding a 5.07% stake in Vesuvius PLC ordinary shares as of October 28, 2026. The disclosure follows regulatory requirements under the Takeover Code, indicating significant interest in the company. Dimensional...

Market News
Neutral
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App